[Serum biomarkers in idiopathic pulmonary fibrosis].
The usefulness of selected serum biomarkers (KL-6, SP-A, SP-D, IL-8, MCP-1, CYFRA-21) in diagnosis, monitoring and prognosis prediction of idiopathic pulmonary fibrosis is discussed in this paper.
Ziora
Dariusz
D
Klinika Chorob Pluc i Gruzlicy, Slaski Uniwersytet Medyczny w Zabrzu, Zabrze, Poland.
D000951:Antigens, Neoplasm / Q000097:blood; D015415:Biomarkers / Q000097:blood*; D002352:Carrier Proteins / Q000097:blood; D018932:Chemokine CCL2 / Q000097:blood; D006801:Humans; D016209:Interleukin-8 / Q000097:blood; D053539:Keratin-19; D007633:Keratins / Q000097:blood; D018396:Mucin-1 / Q000097:blood; D011658:Pulmonary Fibrosis / Q000097:blood* / Q000175:diagnosis*; D037663:Pulmonary Surfactant-Associated Protein D / Q000097:blood
D000951:Antigens, Neoplasm; D015415:Biomarkers; C111835:CCL2 protein, human; D002352:Carrier Proteins; D018932:Chemokine CCL2; D016209:Interleukin-8; D053539:Keratin-19; C060192:MUC1 protein, human; D018396:Mucin-1; D037663:Pulmonary Surfactant-Associated Protein D; C102012:antigen CYFRA21.1; D007633:Keratins